Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

por Conley, Sarah J., Gheordunescu, Elizabeth, Kakarala, Pramod, Newman, Bryan, Korkaya, Hasan, Heath, Amber N., Clouthier, Shawn G., Wicha, Max S.
Publicado 2012

HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of adjuvant trastuzumab

por Ithimakin, Suthinee, Day, Kathleen C., Malik, Fayaz, Zen, Qin, Dawsey, Scott J., Bersano-Begey, Tom F., Quraishi, Ahmed A., Ignatoski, Kathleen Woods, Daignault, Stephanie, Davis, April, Hall, Christopher L., Palanisamy, Nallasivam, Heath, Amber N., Tawakkol, Nader, Luther, Tahra K., Clouthier, Shawn G., Chadwick, Whitney A., Day, Mark L., Kleer, Celina G., Thomas, Dafydd G., Hayes, Daniel F., Korkaya, Hasan, Wicha, Max S.
Publicado 2013